載入...
Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing
Malignant gliomas are aggressive brain tumours with very poor prognosis. The majority of glioma cells are differentiated (glioma-differentiated cells: GDCs), whereas the smaller population (glioma-initiating cells, GICs) is undifferentiated and resistant to conventional therapies. Therefore, to bett...
Na minha lista:
發表在: | PLoS One |
---|---|
Main Authors: | , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Public Library of Science
2016
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5007044/ https://ncbi.nlm.nih.gov/pubmed/27579489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0162105 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|